Luca Salassa

Ikerbasque — Spain

Medicine · Health Sciences

41h-index5.7kcitations322works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metal complexes synthesis and properties(109), X-ray Diffraction in Crystallography(99), Crystallization and Solubility Studies(96), Click Chemistry and Applications(42), Lanthanide and Transition Metal Complexes(37)

Publications321 total

Deciphering How Mutations Tune Flavin Reactivity in miniSOG: QM/MM Insights into Organometallic Prodrug Activation
2025
A Snapshot Of Flavin-Conjugated Pt Anticancer Agents: Pt(IV)-To-Pt(II) Reduction Revealed By X-Ray Fluorescence Imaging And XANES
2025
Author response for "A Snapshot Of Flavin-Conjugated Pt Anticancer Agents: Pt(IV)-To-Pt(II) Reduction Revealed By X-Ray Fluorescence Imaging And XANES"
2025
Author response for "Overcoming flavin-driven inactivation of alcohol dehydrogenases through enzyme immobilization"
2025
A Snapshot Of Flavin-Conjugated Pt Anticancer Agents: Pt(IV)-To-Pt(II) Reduction Revealed By X-Ray Fluorescence Imaging And XANES
2025Open Access
Overcoming Flavin-Driven Inactivation of Alcohol Dehydrogenases Through Enzyme Immobilization
2025Open Access
Choline-Geranate (CAGE) Ionic Liquids Potentiate The Anticancer Activity Of Platinum-Based Drugs
2025Open Access
Choline-Geranate (CAGE) Ionic Liquids Potentiate The Anticancer Activity Of Platinum-Based Drugs
2025Open Access
Catalytic Glutathione Oxidation and Platinum(IV) Prodrug Activation via a Ruthenium-Flavin Catalyst
Organometallics·2025· 1 cited
Catalytic Glutathione Oxidation and Platinum(IV) Prodrug Activation via a Ruthenium-Flavin Catalyst
2025· 1 citedOpen Access
Catalytic Glutathione Oxidation and Platinum(IV) Prodrug Activation via a Ruthenium-Flavin Catalyst
2025Open Access
Choline–geranate (CAGE) ionic liquids potentiate the anticancer activity of platinum-based drugs
Chemical Communications·2025
A snapshot of flavin-conjugated Pt anticancer agents: Pt( <scp>iv</scp> )-to-Pt( <scp>ii</scp> ) reduction revealed by X-ray fluorescence imaging and XANES
Chemical Communications·2025
Overcoming flavin-driven inactivation of alcohol dehydrogenases through enzyme immobilization
Catalysis Science & Technology·2025· 1 citedOpen Access
Redefining platinum(<scp>iv</scp>) chemotherapy: α-tocopherol succinate functionalization and nanoparticle encapsulation to improve cisplatin- and oxaliplatin-based therapies
Dalton Transactions·2025
Red‐Light Photocatalytic Activation of Pt(IV) Anticancer Prodrugs Using Methylene Blue
ChemCatChem·2024· 1 citedOpen Access
Targeting specific brain districts for advanced <scp>nanotherapies</scp>: A review from the perspective of precision nanomedicine
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology·2024· 6 citedOpen Access
Alloxazine-Based Ligands and Their Ruthenium Complexes as NADH Oxidation Catalysts and G4 Binders
Inorganic Chemistry·2024· 4 cited
Red-Light Photocatalytic Activation Of Pt(IV) Anticancer Prodrugs Using Methylene Blue
2024· 1 citedOpen Access
Alloxazine-Based Ligands And Their Ruthenium Complexes As NADH Oxidation Catalysts And G4 Binders
2024
page 1 of 17Next →

Frequent Co-authors

Peter J. Sadler(23), Claudio Garino(15), Abraha Habtemariam(11), Roberto Gobetto(11), Ana M. Pizarro(8), Guy J. Clarkson(8), Silvia Alonso‐de Castro(7), Nicola J. Farrer(6), Carlo Nervi(6), Juan C. Mareque‐Rivas(5), Carlo Lamberti(5), Diego Gianolio(5), Viktor Brabec(4), Julie A. Woods(4), Kim S. Robinson(4), Emmanuel Ruggiero(4), Tiziana Ruiu(4), Yao Zhao(3), Fiona Mackay(3), S. Betanzos-Lara(3)